Prevention of gestational diabetes mellitus: a review of studies on weight management

Morisset, Anne‐Sophie; St-Yves, A.; Veillette, Johanne; Weisnagel, S. John; Tchernof, André; Robitaille, Julie

doi:10.1002/dmrr.1053

Cited by 106 publications

(75 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Interestingly, less weight gain in pregnancy predicted GDM in late pregnancy according to both the WHO and the modified IADPSG criteria. This observation contradicts common wisdom and the vast majority of scientific reports in which increased weight gain has been reported to be associated with GDM (26,27,28,29,30). One report, however, supports our finding (31).…”

Section: Discussioncontrasting

confidence: 99%

Gestational diabetes mellitus among Norwegian women with polycystic ovary syndrome: prevalence and risk factors according to the WHO and the modified IADPSG criteria

Helseth

Salvesen

Carlsen

2013

European Journal of Endocrinology

View full text Add to dashboard Cite

Objective: The consequences of the recently proposed International Association of Diabetes in Pregnancy Study Group (IADPSG) criteria for gestational diabetes mellitus (GDM) in women with polycystic ovary syndrome (PCOS) are not known. We compared the prevalence rates and risk factors for GDM in PCOS women according to both the WHO and the modified IADPSG criteria. Design: Post hoc analyses from a randomized, multicenter study were used. Methods: Fasting and 2-h plasma glucose levels were measured using a 75 g oral glucose tolerance test. GDM was diagnosed according to both the WHO and the modified IADPSG criteria.Results: The prevalence rates of GDM according to the WHO and the modified IADPSG criteria were 9.2 and 15.0% at week 12, 18.7 and 18.7% at week 19, and 25.6 and 24.2% at week 32. Shorter stature and increased insulin levels were correlated with WHO-GDM, but not with modified IADPSG-GDM at weeks 12 and 19. Less weight gain in pregnancy predicted GDM according to both sets of criteria. GDM diagnosis was correlated with less maternal weight loss the first year post-partum. Conclusions: No difference was found in the prevalence of GDM between the two sets of criteria used. Less weight gain in pregnancy was associated with GDM, independent of the diagnostic criteria used. Reduced weight loss the first year post-partum in women with GDM raises the question of whether GDM diagnosis per se or the fact that these women lose less weight after pregnancy predicts later diabetes mellitus.

show abstract

Section: Discussioncontrasting

confidence: 99%

Gestational diabetes mellitus among Norwegian women with polycystic ovary syndrome: prevalence and risk factors according to the WHO and the modified IADPSG criteria

Helseth

Salvesen

Carlsen

2013

European Journal of Endocrinology

View full text Add to dashboard Cite

show abstract

“…23 In addition, weight loss may also limit the risk of developing gestational diabetes. 24 The association between weight loss and subsequent cancer risk is less clear. Most evidence has been derived from breast cancer studies, in which weak or null associations were observed.…”

Section: Modifiable Risk Factorsmentioning

confidence: 99%

Diabetes and Cancer: A Consensus Report

Giovannucci¹,

Harlan²,

Archer³

et al. 2010

CA: A Cancer Journal for Clinicians

1,086

1,061

View full text Add to dashboard Cite

Epidemiologic evidence suggests that cancer incidence is associated with diabetes as well as certain diabetes risk factors and treatments. This consensus statement of experts assembled jointly by the American Diabetes Association and the American Cancer Society reviews the state of science concerning 1) the association between diabetes and cancer incidence or prognosis; 2) risk factors common to both diabetes and cancer; 3) possible biologic links between diabetes and cancer risk; and 4) whether diabetes treatments influence the risk of cancer or cancer prognosis. In addition, key unanswered questions for future research are posed. CA Cancer J Clin 2010;60: 207-221.

show abstract

“…Therefore we concluded that an increased BMI is an important factor for the severity of glucose intolerance. Several studies performed by Buchanan et al 18 , Metzger et al 13 and Morissette AS et al 19 demonstrated that a high BMI is a risk factor for GDM. However, Riskin-Mashiah et al 20 conducted a multivariate analysis in their study and found a significant relationship only between pre-pregnancy BMI and maternal hypererglisemia.…”

Section: Discussionmentioning

confidence: 99%

Farklı Düzeylerde Glukoz İntoleransı Bulunan Gebelerin Kan Şekeri Profilleri ve Perinatal Sonuçlarının Değerlendirilmesi

Selçuk¹,

Kafkaslı²,

Sertkaya³

2016

Ankara Med J

View full text Add to dashboard Cite

Objectives: The aim of this study is to contribute to the monitoring and treatment in pregnant women with different levels of glucose intolerance by comparing blood glucose profiles and perinatal outcomes. Materials and Methods: A 50-gram Glucose Tolerance Test (GTT) was performed on pregnant women between 24th and 28th weeks of pregnancy who admitted to the outpatient clinic followed by a 100-gram OGTT on those who tested positive with 50 g GTT. The patients were allocated into three groups according to the test results as Normal, Abnormal Glucose Challenge Test (AGCT) and Gestational Diabetes Mellitus (GDM). All groups were evaluated in terms of demographic data, GTT and OGTT results, prenatal and postnatal blood glucose profiles, maternal complications, and perinatal outcomes. Results: The prevalence of AGCT was found to be 17.42% while GDM was 14.57%. When compared as to prepregnancy and during 50 g OGTT values, the body mass index (BMI) was found significantly higher in AGTT group than the normal group (p<0.05). Twenty-four hour and postpartum first 24-hour blood glucose profiles of the AGCT group were found to be higher than the normal group (p<0.05), whereas these values were found to be significantly higher in the GDM group when compared to the AGCT group (p<0.05). Conclusion:We found that glucose intolerance in the AGCT group was slightly higher when compared to GDM group and appears to be significantly increased when compared to the normal group. Therefore, we suggest that the pregnant women with AGCT should be followed up closely and treated if needed, similar to the patients diagnosed with GDM in order to prevent both fetal and maternal complications.

show abstract

Prevention of gestational diabetes mellitus: a review of studies on weight management

Cited by 106 publications

References 60 publications

Gestational diabetes mellitus among Norwegian women with polycystic ovary syndrome: prevalence and risk factors according to the WHO and the modified IADPSG criteria

Gestational diabetes mellitus among Norwegian women with polycystic ovary syndrome: prevalence and risk factors according to the WHO and the modified IADPSG criteria

Diabetes and Cancer: A Consensus Report

Farklı Düzeylerde Glukoz İntoleransı Bulunan Gebelerin Kan Şekeri Profilleri ve Perinatal Sonuçlarının Değerlendirilmesi

Contact Info

Product

Resources

About